Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.1%

1 terminated out of 32 trials

Success Rate

95.8%

+9.3% vs benchmark

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

22%

5 of 23 completed with results

Key Signals

5 with results96% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (12)
P 1 (2)
P 2 (7)
P 3 (1)
P 4 (1)

Trial Status

Completed23
Recruiting2
Active Not Recruiting2
Unknown2
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

95.8%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (32)

Showing 20 of 20 trials
NCT01898494Phase 2Active Not RecruitingPrimary

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

NCT01901770Not ApplicableActive Not Recruiting

The Parents in Appalachia Receive Education Needed for Teen Project

NCT04199078Not ApplicableCompleted

Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions.

NCT02258659Phase 2CompletedPrimary

Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer

NCT02135419Phase 3Completed

Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions

NCT06467942Not ApplicableRecruitingPrimary

Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection

NCT05316064Phase 2WithdrawnPrimary

Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotic

NCT05439083Phase 4RecruitingPrimary

Immunogenicity of 9-valent HPV Vaccine

NCT02634190CompletedPrimary

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

NCT06123533UnknownPrimary

Understanding Women's Values in Managing Human Papillomavirus (HPV)

NCT01946139Not ApplicableCompleted

Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV

NCT06111911Not ApplicableCompletedPrimary

Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)

NCT04624568Not ApplicableCompleted

Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance

NCT05694728Phase 2CompletedPrimary

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

NCT03542227CompletedPrimary

Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine

NCT05510830Not ApplicableNot Yet RecruitingPrimary

Diagnostic Cervical Conization for Persistent Infection or Integration of HPV

NCT01567813CompletedPrimary

Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)

NCT04391647CompletedPrimary

Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples

NCT04002154Not ApplicableCompletedPrimary

Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV

NCT04117386CompletedPrimary

Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium

Scroll to load more

Research Network

Activity Timeline